Skip to main content

Narcotic News

Collegium Receives FDA Approval for Xtampza ER, an Analgesic with Abuse-Deterrent Properties

CANTON, Mass., April 26, 2016 (GLOBE NEWSWIRE) – Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced that the U.S. Food and Drug Administration (FDA) approved Xtampza ER (oxycodone)...

FDA Approves Narcan (naloxone) Nasal Spray to Treat Opioid Overdose

November 18, 2015 – Today the U.S. Food and Drug Administration approved Narcan nasal spray, the first FDA-approved nasal spray version of naloxone hydrochloride, a life-saving medication that can...

FDA Approves Evzio (naloxone) Hand-Held Auto-Injector to Reverse Opioid Overdose

April 3, 2014 – The U.S. Food and Drug Administration today approved a prescription treatment that can be used by family members or caregivers to treat a person known or suspected to have had an...

Ask a question

To post your own question to our community, sign in or create an account.